European Commission signs deal to secure access to coronavirus drug remdesivir

The European Commission has signed a €63 million ($74 million) contract with pharmaceutical company Gilead, to secure doses of antiviral drug remdesivir, the first medicine authorised by the EU for treating coronavirus. Pročitaj više